Patent ID: 8828403
Filing Date: 2014-09-09
Classification: A61K,A61P,C12N

Abstract:
1. A therapeutic method for the treatment of a cancer expressing human telomerase, comprising the following steps: A) administering to a subject in need thereof an antitumoral effective amount of 4 peptides from human telomerase wherein said peptides are: in the form of sterile water/oil emulsion wherein the oil component is an adjuvant and consists of: from 88 to 92% by weight of a white mineral oil identified with the CAS Registry No. 8042-47-5, and from 8 to 12% by weight of mannide monooleate, B) administering to the same subject Imiquimod as a further adjuvant, before, contemporaneously or after (A), at the site wherein respectively step (A) will be, is being or was carried out.